These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 36930265)

  • 1. [Cancer of unknown primary-The new ESMO guidelines].
    Bochtler T; Pouyiourou M; Krämer A
    Radiologie (Heidelb); 2023 May; 63(5):329-335. PubMed ID: 36930265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cancer of unknown primary (CUP)-single-site, oligometastatic, and in the head and neck region].
    Pouyiourou M; Regnery S; Bochtler T; Herfarth K; Krämer A
    Radiologie (Heidelb); 2023 May; 63(5):358-365. PubMed ID: 36944857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal Cell Carcinoma Presenting as Carcinoma of Unknown Primary Site: Recognition of a Treatable Patient Subset.
    Greco FA; Hainsworth JD
    Clin Genitourin Cancer; 2018 Aug; 16(4):e893-e898. PubMed ID: 29610002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Challenging Task: Identifying Patients with Cancer of Unknown Primary (CUP) According to ESMO Guidelines: The CUPISCO Trial Experience.
    Pauli C; Bochtler T; Mileshkin L; Baciarello G; Losa F; Ross JS; Pentheroudakis G; Zarkavelis G; Yalcin S; Özgüroğlu M; Beringer A; Scarato J; Mueller-Ohldach M; Thomas M; Moch H; Krämer A
    Oncologist; 2021 May; 26(5):e769-e779. PubMed ID: 33687747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with renal cell carcinoma.
    Kanesvaran R; Porta C; Wong A; Powles T; Ng QS; Schmidinger M; Ye D; Malhotra H; Miura Y; Lee JL; Chong FLT; Pu YS; Yen CC; Saad M; Lee HJ; Kitamura H; Bhattacharyya GS; Curigliano G; Poon E; Choo SP; Peters S; Lim E; Yoshino T; Pentheroudakis G
    ESMO Open; 2021 Dec; 6(6):100304. PubMed ID: 34864348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [CUP syndrome-diagnostics from the perspective of pathology].
    Pauli C
    Radiologie (Heidelb); 2023 May; 63(5):336-345. PubMed ID: 37079060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrospective analysis of clinical characteristics and outcomes of patients with carcinoma of unknown primary from three tertiary centers in Australia.
    Boys EL; Gao B; Grimison P; Sutherland S; MacKenzie KL; Reddel RR; Liu J
    Cancer Med; 2024 Mar; 13(6):e7052. PubMed ID: 38523552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis and management of metastatic neoplasms with unknown primary.
    Bochtler T; Löffler H; Krämer A
    Semin Diagn Pathol; 2018 May; 35(3):199-206. PubMed ID: 29203116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local ablative treatment with surgery and/or radiotherapy in single-site and oligometastatic carcinoma of unknown primary.
    Pouyiourou M; Wohlfromm T; Kraft B; Hielscher T; Stichel D; von Deimling A; Delorme S; Endris V; Neumann O; Stenzinger A; Krämer A; Bochtler T
    Eur J Cancer; 2021 Nov; 157():179-189. PubMed ID: 34521064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carcinoma of Unknown Primary Site (CUP) With Metastatic Renal-Cell Carcinoma (mRCC) Histologic and Immunohistochemical Characteristics (CUP-mRCC): Results From Consecutive Patients Treated With Targeted Therapy and Review of Literature.
    Overby A; Duval L; Ladekarl M; Laursen BE; Donskov F
    Clin Genitourin Cancer; 2019 Feb; 17(1):e32-e37. PubMed ID: 30268423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CUP Syndrome-Metastatic Malignancy with Unknown Primary Tumor.
    Zaun G; Schuler M; Herrmann K; Tannapfel A
    Dtsch Arztebl Int; 2018 Mar; 115(10):157-162. PubMed ID: 29587959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The current management of renal cell carcinoma.
    Kuusk T; Grivas N; de Bruijn R; Bex A
    Minerva Med; 2017 Aug; 108(4):357-369. PubMed ID: 28176516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The initial CUP situation and CUP syndrome: pathological diagnostics].
    Moll R
    Pathologe; 2009 Dec; 30 Suppl 2():161-7. PubMed ID: 19816686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of cancers of unknown primary site (CUP).
    Briasoulis E; Tolis C; Bergh J; Pavlidis N;
    Ann Oncol; 2005; 16 Suppl 1():i75-6. PubMed ID: 15888766
    [No Abstract]   [Full Text] [Related]  

  • 15. Papillary renal cell carcinoma: current and controversial issues.
    Angori S; Lobo J; Moch H
    Curr Opin Urol; 2022 Jul; 32(4):344-351. PubMed ID: 35674688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer of unknown primary (CUP) through the lens of precision oncology: a single institution perspective.
    Weiss L; Heinrich K; Zhang D; Dorman K; Rühlmann K; Hasselmann K; Klauschen F; Kumbrink J; Jung A; Rudelius M; Mock A; Ormanns S; Kunz WG; Roessler D; Beyer G; Corradini S; Heinzerling L; Haas M; von Bergwelt-Baildon M; Boeck S; Heinemann V; Westphalen CB
    J Cancer Res Clin Oncol; 2023 Sep; 149(11):8225-8234. PubMed ID: 37062035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiotherapy Characteristics and Outcomes for Head and Neck Carcinoma of Unknown Primary vs T1 Base-of-Tongue Carcinoma.
    Hosni A; Dixon PR; Rishi A; Au M; Xu W; Song Y; Chepeha DB; Goldstein DP; Huang SH; Kim J; O'Sullivan B; Waldron J; Bratman SV; de Almeida JR
    JAMA Otolaryngol Head Neck Surg; 2016 Dec; 142(12):1208-1215. PubMed ID: 27812692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal cell carcinoma: ESMO clinical recommendations for diagnosis, treatment and follow-up.
    Escudier B; Kataja V;
    Ann Oncol; 2009 May; 20 Suppl 4():81-2. PubMed ID: 19454473
    [No Abstract]   [Full Text] [Related]  

  • 19. Diagnostic work-up of carcinoma of unknown primary: from immunohistochemistry to molecular profiling.
    Oien KA; Dennis JL
    Ann Oncol; 2012 Sep; 23 Suppl 10():x271-7. PubMed ID: 22987975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Escudier B; Porta C; Schmidinger M; Algaba F; Patard JJ; Khoo V; Eisen T; Horwich A;
    Ann Oncol; 2014 Sep; 25 Suppl 3():iii49-56. PubMed ID: 25210086
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.